Avadel Pharmaceuticals PLC (AVDL) — Cash Flow Reinvestment Rate
Avadel Pharmaceuticals PLC (AVDL) has a Cash Flow Reinvestment Rate of 0.36x as of September 2025, reinvesting $8.44 Million (capex $10.76K plus investments $-8.43 Million) from operating cash flow of $23.26 Million. Explore AVDL capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Avadel Pharmaceuticals PLC Cash Flow Reinvestment Rate (2002–2017)
Historical reinvestment intensity for Avadel Pharmaceuticals PLC across 6 annual periods. Also explore AVDL total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Avadel Pharmaceuticals PLC (2002–2017)
Year-by-year capital reinvestment analysis for Avadel Pharmaceuticals PLC. For live market cap and broader valuation context, see AVDL market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 5.50x | $91.71 Million | $16.66 Million | $53.70 Million | ▲ +179.2% |
| 2016 | 1.97x | $37.26 Million | $18.90 Million | $1.20 Million | ▲ +423.7% |
| 2015 | 0.38x | $31.73 Million | $84.29 Million | $1.63 Million | ▲ +74.3% |
| 2009 | 0.22x | $1.77 Million | $8.20 Million | $1.77 Million | ▼ -7.0% |
| 2003 | 0.23x | $2.84 Million | $12.23 Million | $2.84 Million | ▲ +42.0% |
| 2002 | 0.16x | $1.44 Million | $8.77 Million | $1.44 Million | — |